thenoyltrifluoroacetone has been researched along with Cancer Syndromes, Hereditary in 1 studies
Thenoyltrifluoroacetone: Chelating agent and inhibitor of cellular respiration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tong, WH | 1 |
| Sourbier, C | 1 |
| Kovtunovych, G | 1 |
| Jeong, SY | 1 |
| Vira, M | 1 |
| Ghosh, M | 1 |
| Romero, VV | 1 |
| Sougrat, R | 1 |
| Vaulont, S | 1 |
| Viollet, B | 1 |
| Kim, YS | 1 |
| Lee, S | 1 |
| Trepel, J | 1 |
| Srinivasan, R | 1 |
| Bratslavsky, G | 1 |
| Yang, Y | 1 |
| Linehan, WM | 1 |
| Rouault, TA | 1 |
1 other study available for thenoyltrifluoroacetone and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.
Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Basic Helix-Loop- | 2011 |